Skip to main content
Caplight Logo









NeuroBrave

NeuroBrave

Private
JerusalemAI, Data & Cloud Infrastructurehttps://neurobrave.com/

Last Round

Grant

Jul 9, 2024

Total Funding Raised

$1.4M

Company Overview

NeuroBrave is a neurotechnology company that develops an AI-powered software platform, NeuroSpeed OS, which transforms sensory data from wearables and biosensors into real-time cognitive and emotional insights.

Sector

AI, Data & Cloud Infrastructure

Verticals

Health IoT, Smart Manufacturing, Gaming, Sensors, Medical AI

Business Model

B2B

Customer Profile

Subscription SaaS, Usage-Based SaaS

AI Layer

Infrastructure

Keywords

biosignal processingcognitive state monitoringemotion aiwearable aiaffective computingsensor fusiondeep neural networksdnnneurotechnologyreal-time inferenceai software platformhuman-machine interfacehmibiometric analyticsembedded aidigital biomarker

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

NeuroBrave Comparables

Compare NeuroBrave with similar companies based on industry and business-model similarity.

NeuroBrave comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Arctop
81%
Neurable
72%
Emotiv
66%

NeuroBrave Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJul 9, 2024
SeedDec 19, 2022
SeedAug 2, 2021

Key People

Founding team and executive leadership

Oleg Aryutkin

Chief Technology Officer

Executive Team

NeuroBrave Investors

Notable investors and investment history

NeuroBrave investors
InvestorRounds
Labs/02Seed
VentureIsraelSeed
Samurai IncubateSeed
Italian Angels for GrowthSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 4, 2026

    Grew 71% QoQ, from 24 to 41 employees.

  • Jan 1, 2026

    Grew 54% QoQ, from 24 to 37 employees.

NeuroBrave Filings

Explore SEC and related filing metadata, where available.

NeuroBrave filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about NeuroBrave's valuation, stock price, and market status.

Is NeuroBrave a public or private company?

NeuroBrave is a private company.

What is the current stock price of NeuroBrave?

NeuroBrave is a private company with no public stock price. No recent secondary market data is available.

How much is NeuroBrave worth (valuation)?

Valuation information for NeuroBrave is not publicly available.

Can I buy NeuroBrave stock?

NeuroBrave shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was NeuroBrave's last funding round?

NeuroBrave's most recent funding round was Grant on July 9, 2024.

Who are the main investors in NeuroBrave?

Key investors in NeuroBrave include Labs/02, VentureIsrael, Samurai Incubate, Italian Angels for Growth.

Will NeuroBrave IPO soon?

No public IPO plans have been announced for NeuroBrave.

How can I track NeuroBrave secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor NeuroBrave's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersJerusalem
Employee Range32
Year Founded2020
Last FundingJul 9, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?